Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

121
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
121
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

218
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
218
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

135
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
135
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

686
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
686
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

105
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
105
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

115
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
115

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Asynchronous evolution of epithelium and stroma differentiates precursor lesions from pancreatic cancer.

Cancer discovery·2026
Same author

Rewiring Oncogenic Transcriptional Complexes with Domain-ALTeration Chimeras (DALTACs) in Prostate Cancer.

bioRxiv : the preprint server for biology·2026
Same author

ISPAT-3D: Spatially Varying Conditional Volumetric Network Estimation for 3D Tumor Imaging.

bioRxiv : the preprint server for biology·2026
Same author

Mapping the Tumor Microenvironment with Integrative Single-Cell RNA Sequencing and Spatial Proteomics: Uncovering Mechanisms of Disease and Therapeutic Resistance.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

From Raw Data to Biological Insights: A Practical Guide for Spatial Transcriptomics Analysis in R and Python.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Spatially Varying Graphical Models for Cell-Cell Interaction Networks in Multiplexed Tissue Imaging.

bioRxiv : the preprint server for biology·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
Same journal

A Bayesian phase I/II platform design with data augmentation accounting for delayed outcomes.

Biometrics·2026
See all related articles

Related Experiment Video

Updated: Sep 1, 2025

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.4K

Integrative Bayesian models using Post-selective inference: A case study in radiogenomics.

Snigdha Panigrahi1, Shariq Mohammed2,3, Arvind Rao2,3,4,5

  • 1Department of Statistics, University of Michigan, Ann Arbor, Michigan, USA.

Biometrics
|August 16, 2022
PubMed
Summary
This summary is machine-generated.

New Bayesian methods improve disease mechanism insights by accurately selecting genomic and imaging associations. This enhances uncertainty estimation in integrative models for better clinical relevance.

Keywords:
Bayesian methodsconditional inferencegenomic dataintegrative modelspostselection inferenceradiogenomicssparse regression

More Related Videos

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

445
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

864

Related Experiment Videos

Last Updated: Sep 1, 2025

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.4K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

445
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

864

Area of Science:

  • Genomics
  • Biostatistics
  • Medical Imaging

Background:

  • Integrative analyses of genomics and intermediary phenotypes (e.g., imaging) offer insights into disease mechanisms.
  • Accurate inference of uncertainty in these models is crucial but challenged by variable selection bias.

Purpose of the Study:

  • To develop novel selection-aware Bayesian methods to address bias in integrative models.
  • To improve the accuracy of uncertainty estimation in genomic and imaging association studies.

Main Methods:

  • Developed selection-aware Bayesian methods using a "selection-aware posterior".
  • Employed ℓ1-regularized algorithms for variable selection.
  • Utilized a conditional likelihood function with reparameterization for tractable Markov chain Monte Carlo (MCMC) sampling.

Main Results:

  • Successfully counteracted model selection bias in integrative Bayesian models.
  • Achieved accurate uncertainty estimation by balancing selection quality and inferential power.
  • Applied methods to radiogenomic data, identifying key gene pathways associated with patient survival.

Conclusions:

  • The developed selection-aware Bayesian methods provide more reliable insights from integrative genomic and imaging analyses.
  • These methods enhance the clinical relevance of disease mechanism studies by improving uncertainty estimation.
  • The approach is effective for radiogenomic analyses, linking gene pathways to survival outcomes.